Yahoo
NYSE American - Delayed Quote USD

Endovia Health Sciences, Inc. (EDVA)

0.1900 +0.0211 (+12.49%)
At close: 3:59:38 PM EST
0.1899 -0.0001 (-0.05%)
After hours: 4:49:30 PM EST
Chart Range Bar
Loading chart for EDVA
  • Previous Close 0.1689
  • Open 0.1710
  • Bid 0.1886 x 10000
  • Ask 0.1900 x 20000
  • Day's Range 0.1692 - 0.1900
  • 52 Week Range 0.1340 - 6.7600
  • Volume 624,242
  • Avg. Volume 3,380,746
  • Market Cap (intraday) 2.168M
  • Beta (5Y Monthly) -1.11
  • PE Ratio (TTM) --
  • EPS (TTM) -21.9400
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

Endovia Health Sciences, Inc. develops a diversified cannabinoid health sciences platform that translates science into regulated therapies and trusted health and wellness products for people and animals in Ireland, United Kingdom, Australia, and Latin America. Its product includes CannEpil a pharmaceutical-grade cannabinoid formulation comprising cannabidiol and tetrahydrocannabinol isolates in an oral liquid solution. Endovia Health Sciences, Inc. formerly known as Splash Beverage Group, Inc. The company is based in Fort Lauderdale, Florida.

EndoviaSciences.com

1

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

EDVA
93.12%
S&P 500 (^GSPC)
7.76%

1-Year Return

EDVA
96.29%
S&P 500 (^GSPC)
9.77%

3-Year Return

EDVA
99.77%
S&P 500 (^GSPC)
68.96%

5-Year Return

EDVA
99.94%
S&P 500 (^GSPC)
57.04%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY24
Revenue 981.86k
Earnings -4.72M
Profit Margin -480.68%

Q4

FY23

Q1

FY24

Q2

FY24

Q3

FY24

-4M
-2M
0
2M
-500.0%
-400.0%
-300.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -77.70%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    32.09k

  • Net Income Avi to Common (ttm)

    -18.41M

  • Diluted EPS (ttm)

    -21.9400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    242.7k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    2.23M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: